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Abstract
Sacral neuromodulation has had a tremendous impact on the treatment of urinary incontinence and 
lower urinary tract symptoms for patients with neurologic conditions. This stimulation does not 
use real-time data from the body or input from the patient. Incorporating this is the goal of those 
pursuing a neuroprosthesis to enhance bladder function for these patients. Investigators have 
demonstrated the effectiveness of conditional (also called closed-loop) feedback in animal models 
as well as limited human studies. Dorsal genital nerve, pudendal nerve, S3 afferent nerve roots, S1 
and S2 ganglia have all been used as targets for stimulation. Most of these have also been used as 
sources of afferent nerve information using sophisticated nerve electrode arrays and filtering 
algorithms to detect significant bladder events and even to estimate the fullness of the bladder. 
There are problems with afferent nerve sensing, however. Some of these include sensor migration 
and low signal to noise ratios. Implantable pressure sensors have also been investigated that have 
their own unique challenges, such as erosion and sensor drift. As technology improves, an 
intelligent neuroprosthesis with the ability to sense significant bladder events and stimulate as 
needed will evolve.
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Introduction - Why does this matter?
Urinary incontinence affects an estimated 200 million people worldwide [1], at a total 
annual cost of US $19.5 billion in 2000 in the United States alone [2]. Neurologic disease 
contributes to a significant amount of this. It significantly decreases the quality of life in 
those it affects. For decades research has brought advances in diagnosis and treatment, 
consisting of dietary modification, oral medication, and neuromodulation, the most common 
interventions. Despite these advances, a significant number of patients remain frustrated by 
the lack of improvement in the symptoms that prompted them to seek care in the first place.
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Significant advances have been achieved with regard to treating neurogenic bladder, with the 
mainstay consisting of Clean Intermittent Catheterization (CIC) and anticholinergic 
medication to improve continence and decrease resting bladder pressures. The death rate 
from sepsis after a spinal cord injury at one time was 82 times higher than expected based on 
age-matched controls [3]. High pressures in the bladder are thought to contribute to damage 
to the urinary system, renal failure, and incontinence [4]. Detrusor sphincter dyssynergia and 
detrusor overactivity can lead to a high pressure situation. Because of advances in the 
management of the urinary tract after spinal cord injury, urologic problems are no longer the 
leading cause of death after spinal cord injury [5]. In fact, mortality in the first 2 years after 
spinal cord injury has declined by 40%. Despite this success, further improvements in 
quality of life and longer term survival remain elusive [6].
Early experience with sacral neuromodulation for those with neurogenic bladder was 
disappointing, with one early series noting a loss of benefit over a follow up of 54 months in 
all but 1 of 12 patients [7]. Since then, techniques and technology have changed, and now 
multiple authors have demonstrated that neuromodulation is effective in treating neurogenic 
bladders [8-11]. All of these trials, however, employ continuous, or in some cases 
intermittent stimulation that does not take real time data or patient-driven input into account. 
Taking patient data into consideration to modulate therapy is known as “closed-loop 
feedback” and has a long history of success in the field of cardiac pacemakers. The cardiac 
pacemaker was the first electrical stimulator to enjoy widespread implantation in the human 
body. Significant improvements were achieved in cardiac pacing when devices became 
responsive to real-time data from the heart, making therapies such as implantable cardiac 
defibrillation possible [12]. This “closed-loop feedback”, also called conditional stimulation, 
does not currently exist for the bladder and carries significant promise.
There are many reasons that closed loop feedback has not yet been successfully achieved in 
the bladder for treatment of urinary incontinence and neurogenic bladder disease. The first 
and most important is that current sacral neuromodulation therapy has achieved reasonable 
long term success of 81-98% for neurogenic lower urinary tract symptoms (LUTS), and it 
continues to improve[9, 13]. There remains room for improvement, however. Closed loop 
feedback carries many technical challenges, such as how to sense a significant bladder event, 
how to determine the best target for electrical stimulation, and how to stimulate it. One 
might even ask if the increased complexity truly improves outcomes.
Background
Understanding prior work helps to inform contemporary investigators so they can avoid 
duplicating past failures and build on past accomplishments.
Brindley Finetech Stimulator
Introduced in 1978 for patients with neurogenic voiding dysfunction due to complete spinal 
cord injury, the Brindley stimulator has enjoyed moderate success at a limited number of 
centers. The continence comes from the surgical rhizotomy of the dorsal root of the sacral 
nerves and the ability to void comes from stimulation of the anterior roots of S2, S3, and S4 
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(known as Sacral Anterior Root Stimulation, SARS) using a surgically implanted cuff 
electrode. The most recent report on the Brindley stimulator was from the Netherlands. 
When compared with matched spinal cord injured controls, 53% of the 46 patients who 
responded reported urinary continence, compared with 14% of 28 patients who did not 
undergo the procedure. 37% of those with the stimulator reported they no longer used it for 
volitional voiding, but 33% of them still enjoyed improved continence secondary to the 
rhizotomy. Those still using it reported significantly higher quality of life scores [14]. This 
stimulator did not use closed loop feedback, but since the user pressed a button to void it 
does incorporate on-demand patient input effectively, and can serve as a model for future 
devices.
Does Closed-Loop Feedback improve outcomes over continuous 
stimulation?
The earliest appearance of this in the literature involved on-demand penile squeeze or anal 
dilation, which appeared effective at suppressing detrusor overactivity in the majority of 
patients in the 1980s, and serves as the basis for some pelvic floor muscle exercises [15]. 
Still, it not surprising investigators continue to seek an alternative method to improve 
continence.
Early efforts to compare closed-loop feedback directly to continuous stimulation involved 
cats anesthetized with alpha-chloralose. Investigators found that stimulating the pudendal 
nerve after a bladder “event” increased bladder capacity to 38mL, compared to 33mL when 
stimulated continuously (p=0.027), and 28mL with no stimulation. A bladder contraction 
“event” was triggered by a recording of the contralateral pudendal nerve using a cuff 
electrode. A bladder event was defined using a mathematical algorithm and could be 
achieved autonomously, making the technique appealing for an implantable device. Using 
the pudendal nerve electroneurogram as a trigger, however, reduced the reliability of the 
technique, as 2 of the 6 cats tested did not exhibit a bladder “event” despite obvious leakage 
from the urethra [16]. In responders, this effectively increased the bladder capacity by 36% 
and decreased the stimulation time (saving power) by 67%.
The fact that alpha-chloralose was used may be significant because it has been noted to 
cause irritability in the bladder and may decrease the inhibitory effects of neurostimulation 
[17].
Closed loop feedback has also been tested in humans with spinal cord injury, demonstrating 
some improvements in bladder capacity and compliance when compared with continuous 
(conventional) stimulation (173mL increase in capacity vs. 230mL). The dorsal penile nerve 
was stimulated in 6 men with complete spinal cord injury and the bladder ‘event’ to trigger 
stimulation was a 10cm H2O rise in detrusor pressure during urodynamic study. These men 
were compared with 6 other men who underwent urodynamic evaluation with continuous 
penile nerve stimulation, which also reduced Overactivity, but this difference failed to 
achieve statistical significance [18].
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A very similar experiment compared continuous as well as conditional stimulation to lack of 
stimulation of the dorsal genital nerve in 9 spinal cord injured patients and found that 
although maximum cystometric capacity increased by 63cc and 74cc respectively, the 
difference between continuous and conditional stimulation was insignificant [19]. 
Stimulation in this trial was automatic, triggered on a fixed rise in bladder pressure by 
8-12cmH2O. These two are the only human trials thusfar investigating conditional 
stimulation, and only involved the dorsal genital nerve and spinal cord injury.
Recently this concept has also been demonstrated in dogs with improved efficacy, including 
an increase in bladder warning time from 10 seconds to 213 seconds. The continuous group 
received sacral neuromodulation (continuous afferent stimulation), but the conditional 
stimulation group received pudendal stimulation only in response to a bladder contraction 
event. A tripolar cuff electrode was placed around the pudendal nerve which was stimulated 
only in response to a bladder contraction. This was the conditional stimulation group and the 
trigger was a rise in bladder pressure of 5 cmH2O. A moving average calculated over 5 
seconds was used to smooth the signal. Acetic acid 0.4% was used as the irritant to induce 
bladder contractions. Bladder capacity improved from 64mL to 70mL in the dogs receiving 
continuous afferent stimulation and 64mL to 98mL in the dogs receiving only conditional 
electrical stimulation to the pudendal nerve. A third group of dogs was stimulated with both 
continuous afferent stimulation and conditional pudendal stimulation. That group saw an 
increased capacity to 103mL, suggesting a synergy can be achieved by combining 
continuous sacral nerve (S3) stimulation and conditional pudendal stimulation[20]. The 
afferent stimulation was stopped momentarily to apply the pudendal stimulation.
Subject controlled, on-demand Dorsal Genital Nerve Stimulation is one variant of closed 
loop feedback in which the subject triggers the stimulation based on urgency to urinate. 
Investigators enrolled 7 neurologically intact patients to undergo 1 week of stimulation via 
an in-office dorsal genital nerve needle electrode placement. To qualify, subjects had to have 
at least 4 episodes of urge urinary incontinence per day. Not all subjects followed the 
protocol, but 6/7 reported a mean 73% subjective improvement, and heavy incontinence 
episodes (soaked pads) were reduced by 100% in two subjects and by at least 80% in four 
others [21]. Only six patients completed the trial, as one suffered migration of the electrode. 
The stimulation was set to the maximum tolerable amplitude, 20Hz and a 300 microsecond 
pulse width.
By comparison, continuous dorsal genital nerve stimulation was investigated by Goldman 
and colleagues during a 2008 study of 21 women, in which 47% had a >=50% reduction in 
incontinence episodes. Pad weight decreased (76% of those completing the study had a >= 
50% reduction) as well, but 4 did not complete the 24h pad testing [22].
Martens and colleagues applied conditional stimulation of Dorsal Genital Nerve to a group 
of eight spinal cord injured patients. Successful engagement with the nerve was confirmed 
by an anal wink reflex. Three of eight patients did not demonstrate this, but two of these still 
exhibited suppressed detrusor contractions, defined by urodynamic pressure tracing 
returning to “near baseline”. Stimulation was triggered manually by a rise in detrusor 
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pressure of 10cm H2O. Not all detrusor contractions were suppressed, and success was 
considered the ability to suppress one detrusor contraction [23].
Needle electrodes are unattractive to patients, and prior to the study described above, Opisso 
and colleagues examined self-adhesive surface electrodes for on-demand Dorsal Genital 
Nerve stimulation. Their 11 patients experienced an increase in bladder capacity from 
147mL to 204mL, and an increase in mean voided volume as well [24]. These patients 
suffered from neurogenic bladder but had sensation. The cause of the neurogenic bladder 
ranged from multiple sclerosis, to traumatic brain injury, to myelitis, and spinal cord injury.
How do we detect an unwanted detrusor contraction? Using Afferent Nerve 
Activity
The paucity of clinical trials exploring closed loop feedback may be due to the technical 
difficulty in sensing a significant bladder event.
The pudendal nerve has long been a target of sensory algorithms to detect a detrusor 
contraction using afferent nerve information. Investigators in 2004 observed that a cuff 
electrode placed around the pudendal nerve in cats would be able to detect a bladder 
contraction at a mean of 1.2 seconds after it began, allowing the contraction to reach a mean 
amplitude of 7cmH2O. Using a cumulative sum algorithm they were able to achieve 98% 
sensitivity and 55% specificity, suggesting an excellent detection of “bladder events” but 
also a lot of false positives [25]. They used simultaneous urodynamic pressure values to 
validate the pudendal electroneurograms, and the highly processed and filtered signal using 
the cumulative sum algorithm outperformed the signal using a constant threshold and one 
employing a dynamic threshold, which changed as the baseline electroneurogram signal 
increased or decreased, essentially a moving average value.
The pudendal nerve carries more than just bladder information, and it is difficult to detect 
the desired signal from the noise, which in engineering terms leads to a low signal to noise 
ratio. Some have attempted to increase the signal to noise ratio for pudendal sensing with a 
more sophisticated electrode array. The Utah Slanted Electrode Array is designed to obtain 
intra-fasicular recordings and stimulation of the pudendal nerve by perforating the nerve 
with micro-electrodes of varying lengths. The authors note that in the seven cats 
investigated, only a few electrodes exhibited increased firing responses to bladder filling. 
This required a roughly 10 hour implantation technique and a long characterization process 
(about 30 hours total). Histologic examination revealed that the nerve in the cat was only 
about 39% axonal tissue, the rest was empty space, adding to the complexity of 
implantation. Once identified, the electrodes did not consistently sense the stimulus, which 
the authors speculated was due to motion and not nerve damage caused by the electrodes 
[26]••.
Like the pudendal nerve cuff electrode, cuff electrodes placed extradural on the S3 nerve 
root in humans have been hampered by low signal to noise ratios, making it difficult to 
distinguish bladder pressure information from other information carried in this nerve bundle 
[27]. The S1 and S2 dorsal root ganglia are one area where sensory afferents are separated 
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from motor fibers, and in theory, a higher signal to noise ratio can be obtained by sampling 
from this area. Investigators from Pittsburgh, USA explored the feasibility of this by 
implanting neuroelectrode arrays in the S1 and S2 dorsal root ganglia of 3 cats to determine 
if bladder filling could be detected. As the bladder was filled certain dorsal root ganglia units 
could be sensed by the electrode array manifested by an increase in firing rate as the bladder 
was filled, some of which were quiet when the bladder was empty, and some with baseline 
firing activity that increased with filling. This was dependent on the specific position of the 
electrode array and the animal examined. Of the bladder-responsive ganglion units 
identified, firing rate generally began to increase once bladder pressure reached 11cm H2O. 
Once bladder pressure reached 20cmH2O, 92% of the responsive units were registering, 
suggesting that higher pressures might recruit more nerve units, and different populations of 
nerve units might begin to respond at different pressures [28]•.
Using the body's afferent nerves to quantify bladder fullness
Mendez, Wyndaele, and colleagues were able to use pelvic nerve afferent activity to 
distinguish between 3 levels of bladder fullness in rats. They found that after a training 
period, in which nerve units were identified that appeared to respond to bladder fullness, 
they could use those nerve units to distinguish between 25%, 50%, and 100% maximum 
cystometric capacity. This process involved a surgical laminectomy to dissect L6 filaments 
from which the pelvic nerve arises and lay them in a microelectrode array. The complicated 
process may not be practical for widespread use, and the electrode array might damage the 
nerve filaments over time, but this demonstrates that if responsive nerve units can be 
identified then quantitative measurement of bladder fullness is possible using sensory 
afferents[29]••.
Some have taken the approach that bladder pressure is more practical for chronic detection 
of bladder events because there are problems with afferent nerve sensing techniques such as 
instability of the electrode-nerve interface and problems with decoding the information, 
which has yielded variable results[25, 28, 29]. This makes direct sensing of bladder pressure 
more desirable. Unfortunately, early attempts to develop an implantable bladder pressure 
sensor were frustrated by sensor migration and infection in dogs and goats [30, 31]. Recent 
short term results appear encouraging, however. Investigators from Denmark designed a 
13mm implantable pressure sensor and tested it in 6 pigs. They placed it in the wall of the 
bladder and compared it to an intraluminal urodynamic catheter. They found that the wall 
sensor detected a contraction earlier than the urodynamic catheter by an average of 307 
miliseconds. Not all contractions were detected by the wall sensor but the correlation 
coefficient was >0.90. Bladder contractions were evoked by unilateral stimulation of the 
pelvic nerve, and so a precise onset of the contraction was obtained [32]. Sensor drift, or loss 
of accuracy over time, is another significant problem with chronic monitoring of bladder 
pressure, that investigators have improved on recently by encapsulating a sensor in silicone 
oil, isolating the pressure sensing membrane from the physiologic environment [33].
Clinical urodynamic studies typically employ a second pressure sensor placed in the rectum 
to help distinguish abdominal artifact from a true detrusor contraction. Some authors have 
turned to sophisticated algorithms to reliably detect this without the use of a rectal (second) 
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sensor. This type of adaptive event sensing algorithm might be necessary in the future before 
implementation of a true closed-loop feedback system is practical. With this in mind, 
Karam, Damaser, and collegues have refined this work and developed a novel Real-time 
Classification algorithm for detection of bladder contraction that has some ability to 
distinguish artifact from a real event. It has been termed “context aware thresholding”, and 
the authors note a 97% true positive rate, 1.3% false positive rate, using stored urodynamic 
data on 14 human subjects diagnosed with neurogenic bladder [34]. Some other potential 
event triggers investigated included static detection of bladder pressure above a certain 
threshold, such as 10 cm H2O, and the authors note that using this type of detection scheme 
they achieve an inferior rate true positive rate of 76%. The urodynamic data was from 
humans, and included only one contraction per filling phase which was determined by an 
expert observer.
Unconventional ways to sense bladder fullness
Ultra wideband radar has been investigated to sense bladder fullness since it can sense the 
dielectric interface between urine and the bladder wall. A k-Nearest Neighbor learning 
algorithm is trained with a phantom bladder model. It was able to distinguish “full” from 
“medium” to “small” with 91-95% accuracy [35].
Target for stimulation: Pudendal Nerve
Electrodes have been placed on the surface of the skin to stimulate pudendal nerve with 
some decrease in bladder contractions in animal models [36, 37].
Direct stimulation of the pudendal nerve has been done in multiple animal studies, and the 
body of literature in this area is growing. Wark and colleagues use a sophisticated 
microelectrode array (the “Utah” electrode array discussed earlier) placed within the 
fascicules of the pudendal nerve trunk to stimulate as well as inhibit reflexive detrusor 
contractions, as well as restore continence in a denervated model for stress incontinence. 
They describe successfully stimulating contractions in 5/13 neurologically intact animals 
after a long (30 hour) mapping procedure utilizing anesthesia and urodynamic catheters. 
They selectively stimulate combinations of 48 electrodes and map them to muscle responses 
including external anal sphincter contraction, external urethral sphincter contraction, and 
detrusor contraction. The authors were able to induce reflexive voiding contractions by 
filling the bladder in alpha-choralose anesthetized cats in 6/13 animals. In 2 animals, the 
authors were able to inhibit reflex contraction by stimulating the electrode array. A model 
for stress incontinence was created by transecting the right and left pudendal nerves 
proximal to the electrode array and then filling the bladder until a reflexogenic detrusor 
contraction occurs [38]. Unfortunately the leak point pressure did not vary significantly from 
the neurologically intact animals, calling into question the validity of the model. Once 
leakage began, however, it stopped immediately after stimulation was applied, suggesting 
the external urethral sphincter was able to be stimulated via the pudendal electrode array.
There is strong evidence that stimulating the pudendal nerve can both inhibit volume-
induced bladder contractions in spinal cord injured cats and stimulate the bladder to contract 
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without causing a simultaneous contraction in the external urethral sphincter. This provides 
an advantage over sacral afferent root stimulation (SARS), as it does not simultaneously 
contract the sphincter and inhibit voiding as the bladder contracts. Investigators were able to 
reproduce contractions in 14/14 cats stimulated at 33Hz, and inhibition of volume triggered 
detrusor contractions in 8/8 cats stimulated at 10Hz [39].
Anecdotal evidence exists that pudendal nerve stimulation can elicit detrusor contractions in 
humans with spinal cord injury. Two individuals with spinal cord injury were able to achieve 
urodynamic proven detrusor contractions when stimulated at frequencies of 20-50 Hz [40].
Target: S3 Nerve Root
Some investigators have demonstrated that it is possible to distinguish between 3 levels of 
bladder fullness in rats by attaching cuff electrodes to nerve roots carrying primary afferent 
neural activity from bladder mechanoreceptors[29]. Others have developed implantable 
pressure sensors that may one day be used to provide feedback to stimulation devices [41, 
42].
Taken a step further, in theory more selectivity can be achieved by targeting the S1 and S2 
dorsal root ganglia using microelectrode arrays, which have only afferent fibers and are 
more protected from motion by their proximity to the spine. Sensing activity from the 
ganglia was described by Bruns, Weber, and Gaunt in 2011 and they investigate stimulation 
in their 2015 investigation. They succeeded in eliciting reflex voiding in 5/6 cats by 
stimulating select nodes on a microelectrode implanted in the S1 dorsal root ganglia and 
another in the S2 dorsal root ganglia. Unlike some prior investigations, these animals had an 
intact spinal cord. These were long procedures, ranging from 22 to 40 hours, involving a 
long characterization process to determine which microelectrode channels would elicit a 
urodynamic response. Once effective single-channel and multi-channel schemes were 
identified, the average evoked rise in pressure was 16cmH2O, but the investigators found 
that bursts of stimulation could lead to greater evoked potentials [43]•.
Target: Intraspinal Stimulation
Investigators described a novel stimulation technique in which a microelectrode array was 
placed in the dorsal gray commissure at the level of S1 using 22 cats. They noted that 
monthly stimulation over 14 months was able to achieve a strong bladder contraction of at 
least 20cm H2O and a relaxation of the external urinary sphincter of at least 40mmH2O 
[44]. Older data in humans exists where authors describe implanting the electrode in the 
conus medularis of 14 spinal cord injured patients in the USA and 9 in France, but results 
were difficult to achieve, with a laminectomy necessary to place a needle electrode in the 
conus medularis. Patients responded in 60% of the cases, and one might speculate that the 
invasiveness of the procedure coupled with modest results has led to no further papers since 
1981 [45, 46].
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Conclusion
Conditional stimulation, or closed loop feedback, offers the promise of longer battery life, 
more effective prevention of urinary incontinence, and more effective voiding efficiency, 
including initiation of a voiding contraction. The animal literature has demonstrated that 
stimulation can be more effective, but human data is sparse. A reliable method for sensing a 
bladder event remains elusive, but the most promising technologies involve direct bladder 
pressure sensing or recording afferent nerve activity and processing the data with 
sophisticated algorithms to distinguish artifact from a true bladder event. Stimulation has 
been effective when applied to pudendal nerve, dorsal genital nerve, and S3 afferent nerve 
roots. The future of this field is still being written and will be exciting to watch as a 
neuroprosthesis emerges.
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